Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Dec;7(6):519-23.
doi: 10.1093/ckj/sfu118. Epub 2014 Nov 13.

CKD hotspots around the world: where, why and what the lessons are. A CKJ review series

Affiliations

CKD hotspots around the world: where, why and what the lessons are. A CKJ review series

Catalina Martín-Cleary et al. Clin Kidney J. 2014 Dec.

Abstract

Chronic kidney disease (CKD) is one of the three causes of death that has had the highest increase in the last 20 years. The increasing CKD burden occurs in the context of lack of access of most of the world population to adequate healthcare and an incomplete understanding of the pathogenesis of CKD. However, CKD is not homogeneously distributed. CKD hotspots are defined as countries, region, communities or ethnicities with higher than average incidence of CKD. Analysis of CKD hotspots has the potential to provide valuable insights into the pathogenesis of kidney disease and to improve the life expectancy of the affected communities. Examples include ethnicities such as African Americans in the USA or Aboriginals in Australia, regions such as certain Balkan valleys or Central America and even groups of people sharing common activities or interests such as young women trying to lose weight in Belgium. The study of these CKD hotspots has identified underlying genetic factors, such as ApoL1 gene variants, environmental toxins, such as aristolochic acid and socioeconomic factors leading to nutritional deprivation and inflammation/infection. The CKD hotspots series of CKJ reviews will explore the epidemiology and causes in CKD hotspots, beginning with Australian Aboriginals in this issue. An online map of CKD hotspots around the world will feature the reviewed hotspots, highlighting known or suspected causes as well as ongoing projects to unravel the cause and providing a directory of public health officials, physicians and basic scientists involved in these efforts. Since the high prevalence of CKD in a particular region or population may only be known to local physicians, we encourage readers to propose further CKD hotspots to be reviewed.

Keywords: Balkan nephropathy; Chinese herbs; Mesoamerican nephropathy; aristolochic acid; epidemiology; genetics.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
Some examples of CKD hotspots around the world and impact on our current understanding of CKD. By the end of the present CKJ review series, an interactive world map of CKD hotspots will be available at the CKJ website that will allow easy access to manuscripts in this series, and to information on ongoing research projects and epidemiological studies as well as contact information of physicians, researchers and health policy planners who wish to participate.

Similar articles

Cited by

References

    1. Ortiz A, Covic A, Fliser D, et al. Board of the EURECA-m Working Group of ERA-EDTA. Epidemiology, contributors to, and clinical trials of mortality risk in chronic kidney failure. Lancet. 2014;383:1831–1843. - PubMed
    1. Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2095–2128. - PMC - PubMed
    1. Murray CJ, Lopez AD. Measuring the global burden of disease. N Engl J Med. 2013;369:448–457. - PubMed
    1. Murray CJ, Vos T, Lozano R, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2197–2223. - PubMed
    1. Anand S, Bitton A, Gaziano T. The gap between estimated incidence of end-stage renal disease and use of therapy. PLoS One. 2013;8:e72860. - PMC - PubMed